nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—PTGS2—ulcerative colitis	0.187	0.54	CbGaD
Lenalidomide—ABCB1—ulcerative colitis	0.159	0.46	CbGaD
Lenalidomide—PTGS2—Olsalazine—ulcerative colitis	0.0906	0.217	CbGbCtD
Lenalidomide—PTGS2—Balsalazide—ulcerative colitis	0.0807	0.193	CbGbCtD
Lenalidomide—PTGS2—Mesalazine—ulcerative colitis	0.0645	0.154	CbGbCtD
Lenalidomide—PTGS2—Triamcinolone—ulcerative colitis	0.0361	0.0863	CbGbCtD
Lenalidomide—PTGS2—Sulfasalazine—ulcerative colitis	0.0361	0.0863	CbGbCtD
Lenalidomide—PTGS2—Betamethasone—ulcerative colitis	0.0309	0.074	CbGbCtD
Lenalidomide—PTGS2—Dexamethasone—ulcerative colitis	0.018	0.0431	CbGbCtD
Lenalidomide—ABCB1—Methylprednisolone—ulcerative colitis	0.0157	0.0376	CbGbCtD
Lenalidomide—ABCB1—Betamethasone—ulcerative colitis	0.0102	0.0244	CbGbCtD
Lenalidomide—ABCB1—Prednisolone—ulcerative colitis	0.0101	0.0241	CbGbCtD
Lenalidomide—ABCB1—Hydrocortisone—ulcerative colitis	0.00955	0.0228	CbGbCtD
Lenalidomide—ABCB1—Prednisone—ulcerative colitis	0.00951	0.0228	CbGbCtD
Lenalidomide—CDH5—Adherens junctions interactions—CDH3—ulcerative colitis	0.00722	0.123	CbGpPWpGaD
Lenalidomide—ABCB1—Dexamethasone—ulcerative colitis	0.00594	0.0142	CbGbCtD
Lenalidomide—CDH5—Cell-cell junction organization—CDH3—ulcerative colitis	0.00415	0.0704	CbGpPWpGaD
Lenalidomide—CDH5—S1P2 pathway—GNA12—ulcerative colitis	0.00372	0.0631	CbGpPWpGaD
Lenalidomide—TNFSF11—Differentiation Pathway—CXCR1—ulcerative colitis	0.00364	0.0618	CbGpPWpGaD
Lenalidomide—CDH5—Cell junction organization—CDH3—ulcerative colitis	0.00314	0.0533	CbGpPWpGaD
Lenalidomide—TNFSF11—lymphoid tissue—ulcerative colitis	0.00279	0.153	CbGeAlD
Lenalidomide—CDH5—epithelium—ulcerative colitis	0.00272	0.149	CbGeAlD
Lenalidomide—CDH5—smooth muscle tissue—ulcerative colitis	0.00262	0.144	CbGeAlD
Lenalidomide—CDH5—VEGFR2 mediated vascular permeability—CALM3—ulcerative colitis	0.00244	0.0414	CbGpPWpGaD
Lenalidomide—CDH5—Cell-Cell communication—CDH3—ulcerative colitis	0.00223	0.0379	CbGpPWpGaD
Lenalidomide—CDH5—lymphoid tissue—ulcerative colitis	0.0021	0.115	CbGeAlD
Lenalidomide—Thalidomide—NFKB1—ulcerative colitis	0.00204	0.384	CrCbGaD
Lenalidomide—TNFSF11—RANKL/RANK Signaling Pathway—VCAM1—ulcerative colitis	0.00161	0.0273	CbGpPWpGaD
Lenalidomide—CDH5—liver—ulcerative colitis	0.00154	0.0847	CbGeAlD
Lenalidomide—CDH5—Signaling events mediated by VEGFR1 and VEGFR2—PTPN2—ulcerative colitis	0.0014	0.0238	CbGpPWpGaD
Lenalidomide—PTGS2—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.0014	0.0238	CbGpPWpGaD
Lenalidomide—TNFSF11—IL6-mediated signaling events—CRP—ulcerative colitis	0.00135	0.0229	CbGpPWpGaD
Lenalidomide—CRBN—lymphoid tissue—ulcerative colitis	0.00133	0.0731	CbGeAlD
Lenalidomide—CRBN—digestive system—ulcerative colitis	0.00132	0.0722	CbGeAlD
Lenalidomide—CDH5—Signaling events mediated by VEGFR1 and VEGFR2—CALM3—ulcerative colitis	0.0012	0.0204	CbGpPWpGaD
Lenalidomide—CDH5—Adherens junctions interactions—CDH1—ulcerative colitis	0.00119	0.0202	CbGpPWpGaD
Lenalidomide—TNFSF11—RANKL/RANK Signaling Pathway—ICAM1—ulcerative colitis	0.00109	0.0186	CbGpPWpGaD
Lenalidomide—CRBN—liver—ulcerative colitis	0.00098	0.0538	CbGeAlD
Lenalidomide—Pomalidomide—TNF—ulcerative colitis	0.00097	0.183	CrCbGaD
Lenalidomide—TNFSF11—IL6-mediated signaling events—JAK2—ulcerative colitis	0.000961	0.0163	CbGpPWpGaD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—CHP1—ulcerative colitis	0.000851	0.0144	CbGpPWpGaD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—CALM3—ulcerative colitis	0.000834	0.0142	CbGpPWpGaD
Lenalidomide—TNFSF11—RANKL/RANK Signaling Pathway—RELA—ulcerative colitis	0.000821	0.0139	CbGpPWpGaD
Lenalidomide—CDH5—Signaling by VEGF—CALM3—ulcerative colitis	0.000787	0.0134	CbGpPWpGaD
Lenalidomide—TNFSF11—IL6-mediated signaling events—STAT3—ulcerative colitis	0.000706	0.012	CbGpPWpGaD
Lenalidomide—TNFSF11—RANKL/RANK Signaling Pathway—NFKB1—ulcerative colitis	0.000692	0.0118	CbGpPWpGaD
Lenalidomide—CDH5—Cell-cell junction organization—CDH1—ulcerative colitis	0.000684	0.0116	CbGpPWpGaD
Lenalidomide—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000665	0.247	CbGdCrCtD
Lenalidomide—TNFSF11—Differentiation Pathway—TGFB1—ulcerative colitis	0.000643	0.0109	CbGpPWpGaD
Lenalidomide—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—ulcerative colitis	0.000636	0.0108	CbGpPWpGaD
Lenalidomide—Thalidomide—TNF—ulcerative colitis	0.000625	0.118	CrCbGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—ulcerative colitis	0.000577	0.0098	CbGpPWpGaD
Lenalidomide—Thalidomide—PTGS1—ulcerative colitis	0.000519	0.0979	CrCbGaD
Lenalidomide—CDH5—Cell junction organization—CDH1—ulcerative colitis	0.000517	0.00878	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—PRTN3—ulcerative colitis	0.000503	0.00854	CbGpPWpGaD
Lenalidomide—PTGS2—Overview of nanoparticle effects—PTGS1—ulcerative colitis	0.000498	0.00846	CbGpPWpGaD
Lenalidomide—TNFSF11—IL6-mediated signaling events—IL6—ulcerative colitis	0.000493	0.00837	CbGpPWpGaD
Lenalidomide—TNFSF11—Differentiation Pathway—IL6—ulcerative colitis	0.000485	0.00823	CbGpPWpGaD
Lenalidomide—PTGS2—epithelium—ulcerative colitis	0.000471	0.0259	CbGeAlD
Lenalidomide—Pomalidomide—PTGS2—ulcerative colitis	0.000461	0.0869	CrCbGaD
Lenalidomide—PTGS2—smooth muscle tissue—ulcerative colitis	0.000454	0.0249	CbGeAlD
Lenalidomide—ABCB1—Allograft Rejection—MICA—ulcerative colitis	0.00042	0.00713	CbGpPWpGaD
Lenalidomide—PTGS2—Eicosanoid Synthesis—PTGS1—ulcerative colitis	0.000413	0.00702	CbGpPWpGaD
Lenalidomide—Pomalidomide—ABCB1—ulcerative colitis	0.000392	0.0739	CrCbGaD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—JAK2—ulcerative colitis	0.000377	0.00641	CbGpPWpGaD
Lenalidomide—CDH5—Cell-Cell communication—CDH1—ulcerative colitis	0.000368	0.00625	CbGpPWpGaD
Lenalidomide—PTGS2—lymphoid tissue—ulcerative colitis	0.000362	0.0199	CbGeAlD
Lenalidomide—PTGS2—digestive system—ulcerative colitis	0.000358	0.0197	CbGeAlD
Lenalidomide—CDH5—Signaling by VEGF—JAK2—ulcerative colitis	0.000356	0.00605	CbGpPWpGaD
Lenalidomide—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.000351	0.00596	CbGpPWpGaD
Lenalidomide—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	0.000346	0.00587	CbGpPWpGaD
Lenalidomide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—ulcerative colitis	0.00033	0.00561	CbGpPWpGaD
Lenalidomide—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.000321	0.119	CbGdCrCtD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—CALM3—ulcerative colitis	0.00032	0.00543	CbGpPWpGaD
Lenalidomide—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000316	0.118	CbGdCrCtD
Lenalidomide—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000316	0.118	CbGdCrCtD
Lenalidomide—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000309	0.115	CbGdCrCtD
Lenalidomide—Thalidomide—PTGS2—ulcerative colitis	0.000297	0.056	CrCbGaD
Lenalidomide—ABCB1—epithelium—ulcerative colitis	0.000291	0.016	CbGeAlD
Lenalidomide—PTGS2—Overview of nanoparticle effects—CRP—ulcerative colitis	0.000285	0.00483	CbGpPWpGaD
Lenalidomide—ABCB1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.00027	0.00458	CbGpPWpGaD
Lenalidomide—PTGS2—liver—ulcerative colitis	0.000267	0.0147	CbGeAlD
Lenalidomide—PTGS2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.00023	0.0039	CbGpPWpGaD
Lenalidomide—ABCB1—lymphoid tissue—ulcerative colitis	0.000224	0.0123	CbGeAlD
Lenalidomide—ABCB1—digestive system—ulcerative colitis	0.000221	0.0122	CbGeAlD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CALM3—ulcerative colitis	0.000207	0.00351	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—ulcerative colitis	0.000201	0.00341	CbGpPWpGaD
Lenalidomide—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.000194	0.0721	CbGdCrCtD
Lenalidomide—PTGS2—Spinal Cord Injury—MIF—ulcerative colitis	0.000194	0.00329	CbGpPWpGaD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—IL6—ulcerative colitis	0.000193	0.00328	CbGpPWpGaD
Lenalidomide—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.000191	0.0709	CbGdCrCtD
Lenalidomide—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.000191	0.0709	CbGdCrCtD
Lenalidomide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—ulcerative colitis	0.00019	0.00323	CbGpPWpGaD
Lenalidomide—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.000186	0.0693	CbGdCrCtD
Lenalidomide—PTGS2—Overview of nanoparticle effects—CXCL8—ulcerative colitis	0.000185	0.00314	CbGpPWpGaD
Lenalidomide—CDH5—Signaling by VEGF—IL6—ulcerative colitis	0.000183	0.0031	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—SEL1L—ulcerative colitis	0.000172	0.00293	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000168	0.00285	CbGpPWpGaD
Lenalidomide—ABCB1—liver—ulcerative colitis	0.000165	0.00906	CbGeAlD
Lenalidomide—PTGS2—C-MYB transcription factor network—MPO—ulcerative colitis	0.000165	0.0028	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—MPO—ulcerative colitis	0.000159	0.0027	CbGpPWpGaD
Lenalidomide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000155	0.00263	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000146	0.00248	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—PTGS1—ulcerative colitis	0.000146	0.00248	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CXCR1—ulcerative colitis	0.000142	0.00241	CbGpPWpGaD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—ulcerative colitis	0.000142	0.00241	CbGpPWpGaD
Lenalidomide—PTGS2—Overview of nanoparticle effects—TNF—ulcerative colitis	0.000129	0.00219	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—FCGR2A—ulcerative colitis	0.000127	0.00216	CbGpPWpGaD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—ulcerative colitis	0.000126	0.00214	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCL20—ulcerative colitis	0.000125	0.00212	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000119	0.00202	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—GNA12—ulcerative colitis	0.000117	0.00199	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	0.000113	0.00192	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—ulcerative colitis	0.000112	0.0019	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CXCR2—ulcerative colitis	0.000111	0.00189	CbGpPWpGaD
Lenalidomide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000108	0.00183	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	0.000105	0.00178	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCR6—ulcerative colitis	0.000105	0.00177	CbGpPWpGaD
Lenalidomide—PTGS2—Overview of nanoparticle effects—IL6—ulcerative colitis	0.000104	0.00177	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MAML2—ulcerative colitis	9.91e-05	0.00168	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	9.87e-05	0.00168	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	9.68e-05	0.00164	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PTGER4—ulcerative colitis	9.2e-05	0.00156	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—ulcerative colitis	9.18e-05	0.00156	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	8.82e-05	0.0015	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	8.69e-05	0.00148	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—ulcerative colitis	8.54e-05	0.00145	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—GHRL—ulcerative colitis	8.42e-05	0.00143	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—CRP—ulcerative colitis	8.35e-05	0.00142	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	8.17e-05	0.00139	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CALM3—ulcerative colitis	8.16e-05	0.00139	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—ulcerative colitis	8.16e-05	0.00139	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—RIPK2—ulcerative colitis	8.04e-05	0.00136	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—ICAM1—ulcerative colitis	7.68e-05	0.0013	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL10—ulcerative colitis	7.68e-05	0.0013	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	7.33e-05	0.00125	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ADRB2—ulcerative colitis	6.97e-05	0.00118	CbGpPWpGaD
Lenalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	6.97e-05	0.00118	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—ALB—ulcerative colitis	6.4e-05	0.00109	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	6.35e-05	0.00108	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TLR4—ulcerative colitis	6.33e-05	0.00108	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	6.25e-05	0.00106	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	6.18e-05	0.00105	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—ICAM1—ulcerative colitis	6.07e-05	0.00103	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ulcerative colitis	5.94e-05	0.00101	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ADCY5—ulcerative colitis	5.92e-05	0.001	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—CD4—ulcerative colitis	5.85e-05	0.000994	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IFNG—ulcerative colitis	5.84e-05	0.000992	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—RELA—ulcerative colitis	5.76e-05	0.000979	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	5.5e-05	0.000935	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL1B—ulcerative colitis	5.21e-05	0.000885	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	4.86e-05	0.000825	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IFNG—ulcerative colitis	4.62e-05	0.000784	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	4.51e-05	0.000766	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	4.32e-05	0.000734	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	4.32e-05	0.000734	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CXCL8—ulcerative colitis	4.29e-05	0.000729	CbGpPWpGaD
Lenalidomide—Infection—Hydrocortisone—ulcerative colitis	4.2e-05	0.000279	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	4.2e-05	0.000713	CbGpPWpGaD
Lenalidomide—Hyperhidrosis—Prednisolone—ulcerative colitis	4.19e-05	0.000278	CcSEcCtD
Lenalidomide—PTGS2—Disease—CHP1—ulcerative colitis	4.18e-05	0.00071	CbGpPWpGaD
Lenalidomide—Shock—Hydrocortisone—ulcerative colitis	4.16e-05	0.000276	CcSEcCtD
Lenalidomide—Myalgia—Triamcinolone—ulcerative colitis	4.15e-05	0.000276	CcSEcCtD
Lenalidomide—Vomiting—Azathioprine—ulcerative colitis	4.15e-05	0.000276	CcSEcCtD
Lenalidomide—Nervous system disorder—Hydrocortisone—ulcerative colitis	4.15e-05	0.000275	CcSEcCtD
Lenalidomide—Myalgia—Methylprednisolone—ulcerative colitis	4.15e-05	0.000275	CcSEcCtD
Lenalidomide—Arthralgia—Methylprednisolone—ulcerative colitis	4.15e-05	0.000275	CcSEcCtD
Lenalidomide—Eye disorder—Prednisone—ulcerative colitis	4.14e-05	0.000275	CcSEcCtD
Lenalidomide—Anxiety—Methylprednisolone—ulcerative colitis	4.13e-05	0.000274	CcSEcCtD
Lenalidomide—Tachycardia—Hydrocortisone—ulcerative colitis	4.13e-05	0.000274	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—IL1B—ulcerative colitis	4.12e-05	0.0007	CbGpPWpGaD
Lenalidomide—Rash—Azathioprine—ulcerative colitis	4.12e-05	0.000273	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	4.12e-05	0.000273	CcSEcCtD
Lenalidomide—Dermatitis—Azathioprine—ulcerative colitis	4.11e-05	0.000273	CcSEcCtD
Lenalidomide—Flushing—Prednisone—ulcerative colitis	4.11e-05	0.000273	CcSEcCtD
Lenalidomide—Skin disorder—Hydrocortisone—ulcerative colitis	4.11e-05	0.000273	CcSEcCtD
Lenalidomide—Ill-defined disorder—Dexamethasone—ulcerative colitis	4.11e-05	0.000273	CcSEcCtD
Lenalidomide—Ill-defined disorder—Betamethasone—ulcerative colitis	4.11e-05	0.000273	CcSEcCtD
Lenalidomide—Discomfort—Triamcinolone—ulcerative colitis	4.1e-05	0.000272	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—IL2—ulcerative colitis	4.1e-05	0.000697	CbGpPWpGaD
Lenalidomide—Discomfort—Methylprednisolone—ulcerative colitis	4.1e-05	0.000272	CcSEcCtD
Lenalidomide—Headache—Azathioprine—ulcerative colitis	4.09e-05	0.000272	CcSEcCtD
Lenalidomide—Hyperhidrosis—Hydrocortisone—ulcerative colitis	4.09e-05	0.000271	CcSEcCtD
Lenalidomide—Diarrhoea—Mesalazine—ulcerative colitis	4.07e-05	0.00027	CcSEcCtD
Lenalidomide—Dry mouth—Triamcinolone—ulcerative colitis	4.06e-05	0.00027	CcSEcCtD
Lenalidomide—Angioedema—Dexamethasone—ulcerative colitis	4.05e-05	0.000269	CcSEcCtD
Lenalidomide—Angioedema—Betamethasone—ulcerative colitis	4.05e-05	0.000269	CcSEcCtD
Lenalidomide—Anorexia—Hydrocortisone—ulcerative colitis	4.03e-05	0.000268	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	4.03e-05	0.000684	CbGpPWpGaD
Lenalidomide—Angiopathy—Prednisone—ulcerative colitis	4.02e-05	0.000267	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—IL2—ulcerative colitis	4.01e-05	0.000681	CbGpPWpGaD
Lenalidomide—Confusional state—Methylprednisolone—ulcerative colitis	4.01e-05	0.000266	CcSEcCtD
Lenalidomide—Immune system disorder—Prednisone—ulcerative colitis	4e-05	0.000266	CcSEcCtD
Lenalidomide—Malaise—Dexamethasone—ulcerative colitis	3.99e-05	0.000265	CcSEcCtD
Lenalidomide—Malaise—Betamethasone—ulcerative colitis	3.99e-05	0.000265	CcSEcCtD
Lenalidomide—Oedema—Triamcinolone—ulcerative colitis	3.98e-05	0.000264	CcSEcCtD
Lenalidomide—Vertigo—Dexamethasone—ulcerative colitis	3.98e-05	0.000264	CcSEcCtD
Lenalidomide—Vertigo—Betamethasone—ulcerative colitis	3.98e-05	0.000264	CcSEcCtD
Lenalidomide—Syncope—Betamethasone—ulcerative colitis	3.97e-05	0.000264	CcSEcCtD
Lenalidomide—Syncope—Dexamethasone—ulcerative colitis	3.97e-05	0.000264	CcSEcCtD
Lenalidomide—Arrhythmia—Prednisone—ulcerative colitis	3.96e-05	0.000263	CcSEcCtD
Lenalidomide—Infection—Triamcinolone—ulcerative colitis	3.96e-05	0.000263	CcSEcCtD
Lenalidomide—Hypotension—Hydrocortisone—ulcerative colitis	3.95e-05	0.000262	CcSEcCtD
Lenalidomide—Infection—Methylprednisolone—ulcerative colitis	3.95e-05	0.000262	CcSEcCtD
Lenalidomide—Dizziness—Mesalazine—ulcerative colitis	3.93e-05	0.000261	CcSEcCtD
Lenalidomide—Shock—Triamcinolone—ulcerative colitis	3.92e-05	0.00026	CcSEcCtD
Lenalidomide—Insomnia—Prednisolone—ulcerative colitis	3.92e-05	0.00026	CcSEcCtD
Lenalidomide—Alopecia—Prednisone—ulcerative colitis	3.91e-05	0.00026	CcSEcCtD
Lenalidomide—Shock—Methylprednisolone—ulcerative colitis	3.91e-05	0.000259	CcSEcCtD
Lenalidomide—Nervous system disorder—Methylprednisolone—ulcerative colitis	3.9e-05	0.000259	CcSEcCtD
Lenalidomide—Loss of consciousness—Dexamethasone—ulcerative colitis	3.89e-05	0.000258	CcSEcCtD
Lenalidomide—Loss of consciousness—Betamethasone—ulcerative colitis	3.89e-05	0.000258	CcSEcCtD
Lenalidomide—Paraesthesia—Prednisolone—ulcerative colitis	3.89e-05	0.000258	CcSEcCtD
Lenalidomide—Tachycardia—Triamcinolone—ulcerative colitis	3.89e-05	0.000258	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—MMP9—ulcerative colitis	3.88e-05	0.00066	CbGpPWpGaD
Lenalidomide—Mental disorder—Prednisone—ulcerative colitis	3.88e-05	0.000258	CcSEcCtD
Lenalidomide—Nausea—Azathioprine—ulcerative colitis	3.88e-05	0.000257	CcSEcCtD
Lenalidomide—Tachycardia—Methylprednisolone—ulcerative colitis	3.88e-05	0.000257	CcSEcCtD
Lenalidomide—Skin disorder—Methylprednisolone—ulcerative colitis	3.86e-05	0.000256	CcSEcCtD
Lenalidomide—Erythema—Prednisone—ulcerative colitis	3.86e-05	0.000256	CcSEcCtD
Lenalidomide—Malnutrition—Prednisone—ulcerative colitis	3.86e-05	0.000256	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	3.85e-05	0.000256	CcSEcCtD
Lenalidomide—Hyperhidrosis—Triamcinolone—ulcerative colitis	3.85e-05	0.000256	CcSEcCtD
Lenalidomide—Hyperhidrosis—Methylprednisolone—ulcerative colitis	3.84e-05	0.000255	CcSEcCtD
Lenalidomide—Insomnia—Hydrocortisone—ulcerative colitis	3.83e-05	0.000254	CcSEcCtD
Lenalidomide—Hypertension—Dexamethasone—ulcerative colitis	3.82e-05	0.000254	CcSEcCtD
Lenalidomide—Hypertension—Betamethasone—ulcerative colitis	3.82e-05	0.000254	CcSEcCtD
Lenalidomide—Paraesthesia—Hydrocortisone—ulcerative colitis	3.8e-05	0.000252	CcSEcCtD
Lenalidomide—Vomiting—Mesalazine—ulcerative colitis	3.78e-05	0.000251	CcSEcCtD
Lenalidomide—PTGS2—Selenium Micronutrient Network—TNF—ulcerative colitis	3.78e-05	0.000642	CbGpPWpGaD
Lenalidomide—Myalgia—Dexamethasone—ulcerative colitis	3.77e-05	0.00025	CcSEcCtD
Lenalidomide—Myalgia—Betamethasone—ulcerative colitis	3.77e-05	0.00025	CcSEcCtD
Lenalidomide—Anxiety—Dexamethasone—ulcerative colitis	3.76e-05	0.000249	CcSEcCtD
Lenalidomide—Anxiety—Betamethasone—ulcerative colitis	3.76e-05	0.000249	CcSEcCtD
Lenalidomide—Rash—Mesalazine—ulcerative colitis	3.75e-05	0.000249	CcSEcCtD
Lenalidomide—Dermatitis—Mesalazine—ulcerative colitis	3.75e-05	0.000249	CcSEcCtD
Lenalidomide—Headache—Mesalazine—ulcerative colitis	3.73e-05	0.000247	CcSEcCtD
Lenalidomide—Discomfort—Betamethasone—ulcerative colitis	3.72e-05	0.000247	CcSEcCtD
Lenalidomide—Discomfort—Dexamethasone—ulcerative colitis	3.72e-05	0.000247	CcSEcCtD
Lenalidomide—Dyspepsia—Hydrocortisone—ulcerative colitis	3.72e-05	0.000247	CcSEcCtD
Lenalidomide—Hypotension—Methylprednisolone—ulcerative colitis	3.71e-05	0.000246	CcSEcCtD
Lenalidomide—Pain—Prednisolone—ulcerative colitis	3.7e-05	0.000246	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—JAK2—ulcerative colitis	3.69e-05	0.000627	CbGpPWpGaD
Lenalidomide—Decreased appetite—Hydrocortisone—ulcerative colitis	3.68e-05	0.000244	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	3.65e-05	0.000242	CcSEcCtD
Lenalidomide—Fatigue—Hydrocortisone—ulcerative colitis	3.65e-05	0.000242	CcSEcCtD
Lenalidomide—Vision blurred—Prednisone—ulcerative colitis	3.63e-05	0.000241	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	3.63e-05	0.000241	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	3.62e-05	0.00024	CcSEcCtD
Lenalidomide—Pain—Hydrocortisone—ulcerative colitis	3.62e-05	0.00024	CcSEcCtD
Lenalidomide—Oedema—Dexamethasone—ulcerative colitis	3.61e-05	0.00024	CcSEcCtD
Lenalidomide—Oedema—Betamethasone—ulcerative colitis	3.61e-05	0.00024	CcSEcCtD
Lenalidomide—Insomnia—Triamcinolone—ulcerative colitis	3.6e-05	0.000239	CcSEcCtD
Lenalidomide—Insomnia—Methylprednisolone—ulcerative colitis	3.59e-05	0.000239	CcSEcCtD
Lenalidomide—Infection—Betamethasone—ulcerative colitis	3.59e-05	0.000238	CcSEcCtD
Lenalidomide—Infection—Dexamethasone—ulcerative colitis	3.59e-05	0.000238	CcSEcCtD
Lenalidomide—Ill-defined disorder—Prednisone—ulcerative colitis	3.58e-05	0.000237	CcSEcCtD
Lenalidomide—Paraesthesia—Triamcinolone—ulcerative colitis	3.58e-05	0.000237	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—RELA—ulcerative colitis	3.57e-05	0.000607	CbGpPWpGaD
Lenalidomide—Feeling abnormal—Prednisolone—ulcerative colitis	3.57e-05	0.000237	CcSEcCtD
Lenalidomide—Paraesthesia—Methylprednisolone—ulcerative colitis	3.57e-05	0.000237	CcSEcCtD
Lenalidomide—Anaemia—Prednisone—ulcerative colitis	3.56e-05	0.000237	CcSEcCtD
Lenalidomide—Shock—Dexamethasone—ulcerative colitis	3.56e-05	0.000236	CcSEcCtD
Lenalidomide—Shock—Betamethasone—ulcerative colitis	3.56e-05	0.000236	CcSEcCtD
Lenalidomide—Dyspnoea—Triamcinolone—ulcerative colitis	3.55e-05	0.000236	CcSEcCtD
Lenalidomide—Nervous system disorder—Dexamethasone—ulcerative colitis	3.54e-05	0.000235	CcSEcCtD
Lenalidomide—Nervous system disorder—Betamethasone—ulcerative colitis	3.54e-05	0.000235	CcSEcCtD
Lenalidomide—Agitation—Prednisone—ulcerative colitis	3.54e-05	0.000235	CcSEcCtD
Lenalidomide—Thrombocytopenia—Dexamethasone—ulcerative colitis	3.54e-05	0.000235	CcSEcCtD
Lenalidomide—Thrombocytopenia—Betamethasone—ulcerative colitis	3.54e-05	0.000235	CcSEcCtD
Lenalidomide—Nausea—Mesalazine—ulcerative colitis	3.53e-05	0.000235	CcSEcCtD
Lenalidomide—Tachycardia—Dexamethasone—ulcerative colitis	3.53e-05	0.000234	CcSEcCtD
Lenalidomide—Tachycardia—Betamethasone—ulcerative colitis	3.53e-05	0.000234	CcSEcCtD
Lenalidomide—Angioedema—Prednisone—ulcerative colitis	3.52e-05	0.000234	CcSEcCtD
Lenalidomide—Dyspepsia—Triamcinolone—ulcerative colitis	3.51e-05	0.000233	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—CHP1—ulcerative colitis	3.5e-05	0.000595	CbGpPWpGaD
Lenalidomide—Dyspepsia—Methylprednisolone—ulcerative colitis	3.5e-05	0.000232	CcSEcCtD
Lenalidomide—Hyperhidrosis—Dexamethasone—ulcerative colitis	3.49e-05	0.000232	CcSEcCtD
Lenalidomide—Hyperhidrosis—Betamethasone—ulcerative colitis	3.49e-05	0.000232	CcSEcCtD
Lenalidomide—Feeling abnormal—Hydrocortisone—ulcerative colitis	3.49e-05	0.000231	CcSEcCtD
Lenalidomide—Malaise—Prednisone—ulcerative colitis	3.48e-05	0.000231	CcSEcCtD
Lenalidomide—Vertigo—Prednisone—ulcerative colitis	3.46e-05	0.00023	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	3.46e-05	0.00023	CcSEcCtD
Lenalidomide—Syncope—Prednisone—ulcerative colitis	3.46e-05	0.00023	CcSEcCtD
Lenalidomide—Anorexia—Betamethasone—ulcerative colitis	3.44e-05	0.000229	CcSEcCtD
Lenalidomide—Anorexia—Dexamethasone—ulcerative colitis	3.44e-05	0.000229	CcSEcCtD
Lenalidomide—Urticaria—Prednisolone—ulcerative colitis	3.44e-05	0.000228	CcSEcCtD
Lenalidomide—Fatigue—Triamcinolone—ulcerative colitis	3.43e-05	0.000228	CcSEcCtD
Lenalidomide—Fatigue—Methylprednisolone—ulcerative colitis	3.43e-05	0.000227	CcSEcCtD
Lenalidomide—Pain—Triamcinolone—ulcerative colitis	3.41e-05	0.000226	CcSEcCtD
Lenalidomide—Loss of consciousness—Prednisone—ulcerative colitis	3.39e-05	0.000225	CcSEcCtD
Lenalidomide—Hypotension—Betamethasone—ulcerative colitis	3.38e-05	0.000224	CcSEcCtD
Lenalidomide—Hypotension—Dexamethasone—ulcerative colitis	3.38e-05	0.000224	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—CXCL8—ulcerative colitis	3.37e-05	0.000572	CbGpPWpGaD
Lenalidomide—Urticaria—Hydrocortisone—ulcerative colitis	3.36e-05	0.000223	CcSEcCtD
Lenalidomide—Abdominal pain—Hydrocortisone—ulcerative colitis	3.34e-05	0.000222	CcSEcCtD
Lenalidomide—Body temperature increased—Hydrocortisone—ulcerative colitis	3.34e-05	0.000222	CcSEcCtD
Lenalidomide—Hypertension—Prednisone—ulcerative colitis	3.33e-05	0.000221	CcSEcCtD
Lenalidomide—PTGS2—Disease—SEL1L—ulcerative colitis	3.32e-05	0.000564	CbGpPWpGaD
Lenalidomide—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	3.29e-05	0.000219	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	3.29e-05	0.000219	CcSEcCtD
Lenalidomide—Arthralgia—Prednisone—ulcerative colitis	3.28e-05	0.000218	CcSEcCtD
Lenalidomide—Myalgia—Prednisone—ulcerative colitis	3.28e-05	0.000218	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.28e-05	0.000557	CbGpPWpGaD
Lenalidomide—Feeling abnormal—Triamcinolone—ulcerative colitis	3.28e-05	0.000218	CcSEcCtD
Lenalidomide—Feeling abnormal—Methylprednisolone—ulcerative colitis	3.27e-05	0.000217	CcSEcCtD
Lenalidomide—Anxiety—Prednisone—ulcerative colitis	3.27e-05	0.000217	CcSEcCtD
Lenalidomide—Insomnia—Betamethasone—ulcerative colitis	3.27e-05	0.000217	CcSEcCtD
Lenalidomide—Insomnia—Dexamethasone—ulcerative colitis	3.27e-05	0.000217	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	3.26e-05	0.000216	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	3.25e-05	0.000216	CcSEcCtD
Lenalidomide—Paraesthesia—Dexamethasone—ulcerative colitis	3.24e-05	0.000215	CcSEcCtD
Lenalidomide—Paraesthesia—Betamethasone—ulcerative colitis	3.24e-05	0.000215	CcSEcCtD
Lenalidomide—Discomfort—Prednisone—ulcerative colitis	3.24e-05	0.000215	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—IL2—ulcerative colitis	3.22e-05	0.000546	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	3.2e-05	0.000544	CbGpPWpGaD
Lenalidomide—Hypersensitivity—Prednisolone—ulcerative colitis	3.19e-05	0.000212	CcSEcCtD
Lenalidomide—Dyspepsia—Dexamethasone—ulcerative colitis	3.18e-05	0.000211	CcSEcCtD
Lenalidomide—Dyspepsia—Betamethasone—ulcerative colitis	3.18e-05	0.000211	CcSEcCtD
Lenalidomide—Urticaria—Triamcinolone—ulcerative colitis	3.16e-05	0.00021	CcSEcCtD
Lenalidomide—Urticaria—Methylprednisolone—ulcerative colitis	3.16e-05	0.00021	CcSEcCtD
Lenalidomide—Body temperature increased—Triamcinolone—ulcerative colitis	3.15e-05	0.000209	CcSEcCtD
Lenalidomide—Oedema—Prednisone—ulcerative colitis	3.15e-05	0.000209	CcSEcCtD
Lenalidomide—Abdominal pain—Methylprednisolone—ulcerative colitis	3.14e-05	0.000209	CcSEcCtD
Lenalidomide—Decreased appetite—Dexamethasone—ulcerative colitis	3.14e-05	0.000209	CcSEcCtD
Lenalidomide—Decreased appetite—Betamethasone—ulcerative colitis	3.14e-05	0.000209	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	3.13e-05	0.000531	CbGpPWpGaD
Lenalidomide—Infection—Prednisone—ulcerative colitis	3.13e-05	0.000208	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Betamethasone—ulcerative colitis	3.12e-05	0.000207	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	3.12e-05	0.000207	CcSEcCtD
Lenalidomide—Hypersensitivity—Hydrocortisone—ulcerative colitis	3.12e-05	0.000207	CcSEcCtD
Lenalidomide—Fatigue—Dexamethasone—ulcerative colitis	3.12e-05	0.000207	CcSEcCtD
Lenalidomide—Fatigue—Betamethasone—ulcerative colitis	3.12e-05	0.000207	CcSEcCtD
Lenalidomide—Shock—Prednisone—ulcerative colitis	3.1e-05	0.000206	CcSEcCtD
Lenalidomide—Pain—Betamethasone—ulcerative colitis	3.09e-05	0.000205	CcSEcCtD
Lenalidomide—Pain—Dexamethasone—ulcerative colitis	3.09e-05	0.000205	CcSEcCtD
Lenalidomide—Nervous system disorder—Prednisone—ulcerative colitis	3.09e-05	0.000205	CcSEcCtD
Lenalidomide—Tachycardia—Prednisone—ulcerative colitis	3.07e-05	0.000204	CcSEcCtD
Lenalidomide—Skin disorder—Prednisone—ulcerative colitis	3.06e-05	0.000203	CcSEcCtD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	3.05e-05	0.000518	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MMP9—ulcerative colitis	3.05e-05	0.000517	CbGpPWpGaD
Lenalidomide—Hyperhidrosis—Prednisone—ulcerative colitis	3.04e-05	0.000202	CcSEcCtD
Lenalidomide—Asthenia—Hydrocortisone—ulcerative colitis	3.03e-05	0.000201	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—DLD—ulcerative colitis	3.02e-05	0.000513	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NFKB1—ulcerative colitis	3.01e-05	0.000512	CbGpPWpGaD
Lenalidomide—Anorexia—Prednisone—ulcerative colitis	3e-05	0.000199	CcSEcCtD
Lenalidomide—Pruritus—Hydrocortisone—ulcerative colitis	2.99e-05	0.000199	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	2.99e-05	0.000508	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—LTF—ulcerative colitis	2.98e-05	0.000506	CbGpPWpGaD
Lenalidomide—Feeling abnormal—Betamethasone—ulcerative colitis	2.98e-05	0.000198	CcSEcCtD
Lenalidomide—Feeling abnormal—Dexamethasone—ulcerative colitis	2.98e-05	0.000198	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Dexamethasone—ulcerative colitis	2.96e-05	0.000196	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Betamethasone—ulcerative colitis	2.96e-05	0.000196	CcSEcCtD
Lenalidomide—Hypersensitivity—Triamcinolone—ulcerative colitis	2.93e-05	0.000195	CcSEcCtD
Lenalidomide—Hypersensitivity—Methylprednisolone—ulcerative colitis	2.93e-05	0.000194	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—TNF—ulcerative colitis	2.92e-05	0.000496	CbGpPWpGaD
Lenalidomide—Diarrhoea—Hydrocortisone—ulcerative colitis	2.89e-05	0.000192	CcSEcCtD
Lenalidomide—Urticaria—Dexamethasone—ulcerative colitis	2.87e-05	0.000191	CcSEcCtD
Lenalidomide—Urticaria—Betamethasone—ulcerative colitis	2.87e-05	0.000191	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Prednisone—ulcerative colitis	2.87e-05	0.00019	CcSEcCtD
Lenalidomide—Dizziness—Prednisolone—ulcerative colitis	2.86e-05	0.00019	CcSEcCtD
Lenalidomide—Asthenia—Triamcinolone—ulcerative colitis	2.86e-05	0.00019	CcSEcCtD
Lenalidomide—Abdominal pain—Dexamethasone—ulcerative colitis	2.86e-05	0.00019	CcSEcCtD
Lenalidomide—Abdominal pain—Betamethasone—ulcerative colitis	2.86e-05	0.00019	CcSEcCtD
Lenalidomide—Body temperature increased—Dexamethasone—ulcerative colitis	2.86e-05	0.00019	CcSEcCtD
Lenalidomide—Body temperature increased—Betamethasone—ulcerative colitis	2.86e-05	0.00019	CcSEcCtD
Lenalidomide—Asthenia—Methylprednisolone—ulcerative colitis	2.85e-05	0.000189	CcSEcCtD
Lenalidomide—Insomnia—Prednisone—ulcerative colitis	2.85e-05	0.000189	CcSEcCtD
Lenalidomide—Paraesthesia—Prednisone—ulcerative colitis	2.83e-05	0.000188	CcSEcCtD
Lenalidomide—Pruritus—Triamcinolone—ulcerative colitis	2.82e-05	0.000187	CcSEcCtD
Lenalidomide—Pruritus—Methylprednisolone—ulcerative colitis	2.81e-05	0.000187	CcSEcCtD
Lenalidomide—Dizziness—Hydrocortisone—ulcerative colitis	2.8e-05	0.000186	CcSEcCtD
Lenalidomide—Dyspepsia—Prednisone—ulcerative colitis	2.77e-05	0.000184	CcSEcCtD
Lenalidomide—Decreased appetite—Prednisone—ulcerative colitis	2.74e-05	0.000182	CcSEcCtD
Lenalidomide—Rash—Prednisolone—ulcerative colitis	2.73e-05	0.000181	CcSEcCtD
Lenalidomide—Dermatitis—Prednisolone—ulcerative colitis	2.73e-05	0.000181	CcSEcCtD
Lenalidomide—Diarrhoea—Methylprednisolone—ulcerative colitis	2.72e-05	0.00018	CcSEcCtD
Lenalidomide—Fatigue—Prednisone—ulcerative colitis	2.71e-05	0.00018	CcSEcCtD
Lenalidomide—Headache—Prednisolone—ulcerative colitis	2.71e-05	0.00018	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—STAT3—ulcerative colitis	2.71e-05	0.00046	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.69e-05	0.000457	CbGpPWpGaD
Lenalidomide—Constipation—Prednisone—ulcerative colitis	2.69e-05	0.000179	CcSEcCtD
Lenalidomide—Vomiting—Hydrocortisone—ulcerative colitis	2.69e-05	0.000179	CcSEcCtD
Lenalidomide—Rash—Hydrocortisone—ulcerative colitis	2.67e-05	0.000177	CcSEcCtD
Lenalidomide—Dermatitis—Hydrocortisone—ulcerative colitis	2.66e-05	0.000177	CcSEcCtD
Lenalidomide—Headache—Hydrocortisone—ulcerative colitis	2.65e-05	0.000176	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	2.64e-05	0.000448	CbGpPWpGaD
Lenalidomide—Dizziness—Triamcinolone—ulcerative colitis	2.63e-05	0.000175	CcSEcCtD
Lenalidomide—Dizziness—Methylprednisolone—ulcerative colitis	2.63e-05	0.000174	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.61e-05	0.000444	CbGpPWpGaD
Lenalidomide—Feeling abnormal—Prednisone—ulcerative colitis	2.59e-05	0.000172	CcSEcCtD
Lenalidomide—Asthenia—Dexamethasone—ulcerative colitis	2.59e-05	0.000172	CcSEcCtD
Lenalidomide—Asthenia—Betamethasone—ulcerative colitis	2.59e-05	0.000172	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Prednisone—ulcerative colitis	2.57e-05	0.000171	CcSEcCtD
Lenalidomide—Nausea—Prednisolone—ulcerative colitis	2.57e-05	0.000171	CcSEcCtD
Lenalidomide—Pruritus—Dexamethasone—ulcerative colitis	2.56e-05	0.00017	CcSEcCtD
Lenalidomide—Pruritus—Betamethasone—ulcerative colitis	2.56e-05	0.00017	CcSEcCtD
Lenalidomide—Vomiting—Triamcinolone—ulcerative colitis	2.53e-05	0.000168	CcSEcCtD
Lenalidomide—Vomiting—Methylprednisolone—ulcerative colitis	2.53e-05	0.000168	CcSEcCtD
Lenalidomide—Nausea—Hydrocortisone—ulcerative colitis	2.51e-05	0.000167	CcSEcCtD
Lenalidomide—Rash—Triamcinolone—ulcerative colitis	2.51e-05	0.000167	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—TGFB1—ulcerative colitis	2.51e-05	0.000426	CbGpPWpGaD
Lenalidomide—Dermatitis—Triamcinolone—ulcerative colitis	2.51e-05	0.000167	CcSEcCtD
Lenalidomide—Rash—Methylprednisolone—ulcerative colitis	2.51e-05	0.000166	CcSEcCtD
Lenalidomide—Dermatitis—Methylprednisolone—ulcerative colitis	2.5e-05	0.000166	CcSEcCtD
Lenalidomide—Urticaria—Prednisone—ulcerative colitis	2.5e-05	0.000166	CcSEcCtD
Lenalidomide—Headache—Triamcinolone—ulcerative colitis	2.5e-05	0.000166	CcSEcCtD
Lenalidomide—Headache—Methylprednisolone—ulcerative colitis	2.49e-05	0.000165	CcSEcCtD
Lenalidomide—Body temperature increased—Prednisone—ulcerative colitis	2.49e-05	0.000165	CcSEcCtD
Lenalidomide—Abdominal pain—Prednisone—ulcerative colitis	2.49e-05	0.000165	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—CHP1—ulcerative colitis	2.48e-05	0.000422	CbGpPWpGaD
Lenalidomide—Diarrhoea—Dexamethasone—ulcerative colitis	2.47e-05	0.000164	CcSEcCtD
Lenalidomide—Diarrhoea—Betamethasone—ulcerative colitis	2.47e-05	0.000164	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	2.41e-05	0.00041	CbGpPWpGaD
Lenalidomide—Dizziness—Dexamethasone—ulcerative colitis	2.39e-05	0.000159	CcSEcCtD
Lenalidomide—Dizziness—Betamethasone—ulcerative colitis	2.39e-05	0.000159	CcSEcCtD
Lenalidomide—Nausea—Triamcinolone—ulcerative colitis	2.37e-05	0.000157	CcSEcCtD
Lenalidomide—Nausea—Methylprednisolone—ulcerative colitis	2.36e-05	0.000157	CcSEcCtD
Lenalidomide—Hypersensitivity—Prednisone—ulcerative colitis	2.32e-05	0.000154	CcSEcCtD
Lenalidomide—Vomiting—Dexamethasone—ulcerative colitis	2.3e-05	0.000153	CcSEcCtD
Lenalidomide—Vomiting—Betamethasone—ulcerative colitis	2.3e-05	0.000153	CcSEcCtD
Lenalidomide—Rash—Betamethasone—ulcerative colitis	2.28e-05	0.000151	CcSEcCtD
Lenalidomide—Rash—Dexamethasone—ulcerative colitis	2.28e-05	0.000151	CcSEcCtD
Lenalidomide—Dermatitis—Dexamethasone—ulcerative colitis	2.28e-05	0.000151	CcSEcCtD
Lenalidomide—Dermatitis—Betamethasone—ulcerative colitis	2.28e-05	0.000151	CcSEcCtD
Lenalidomide—Headache—Betamethasone—ulcerative colitis	2.26e-05	0.00015	CcSEcCtD
Lenalidomide—Headache—Dexamethasone—ulcerative colitis	2.26e-05	0.00015	CcSEcCtD
Lenalidomide—Asthenia—Prednisone—ulcerative colitis	2.26e-05	0.00015	CcSEcCtD
Lenalidomide—Pruritus—Prednisone—ulcerative colitis	2.23e-05	0.000148	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	2.18e-05	0.00037	CbGpPWpGaD
Lenalidomide—Diarrhoea—Prednisone—ulcerative colitis	2.15e-05	0.000143	CcSEcCtD
Lenalidomide—Nausea—Betamethasone—ulcerative colitis	2.15e-05	0.000142	CcSEcCtD
Lenalidomide—Nausea—Dexamethasone—ulcerative colitis	2.15e-05	0.000142	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—DLD—ulcerative colitis	2.14e-05	0.000364	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.14e-05	0.000363	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SLC11A1—ulcerative colitis	2.12e-05	0.000361	CbGpPWpGaD
Lenalidomide—Dizziness—Prednisone—ulcerative colitis	2.08e-05	0.000138	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—TP53—ulcerative colitis	2.07e-05	0.000351	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	2.03e-05	0.000345	CbGpPWpGaD
Lenalidomide—Vomiting—Prednisone—ulcerative colitis	2e-05	0.000133	CcSEcCtD
Lenalidomide—Rash—Prednisone—ulcerative colitis	1.98e-05	0.000132	CcSEcCtD
Lenalidomide—Dermatitis—Prednisone—ulcerative colitis	1.98e-05	0.000132	CcSEcCtD
Lenalidomide—Headache—Prednisone—ulcerative colitis	1.97e-05	0.000131	CcSEcCtD
Lenalidomide—PTGS2—Disease—MAML2—ulcerative colitis	1.91e-05	0.000324	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL6—ulcerative colitis	1.89e-05	0.000321	CbGpPWpGaD
Lenalidomide—Nausea—Prednisone—ulcerative colitis	1.87e-05	0.000124	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.85e-05	0.000315	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.79e-05	0.000304	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.6e-05	0.000272	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CALM3—ulcerative colitis	1.57e-05	0.000267	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.54e-05	0.000262	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PTGS1—ulcerative colitis	1.46e-05	0.000248	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.45e-05	0.000245	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.44e-05	0.000245	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.44e-05	0.000244	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CALM3—ulcerative colitis	1.32e-05	0.000223	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.27e-05	0.000216	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ADCY5—ulcerative colitis	1.14e-05	0.000194	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.04e-05	0.000176	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ABCB1—ulcerative colitis	1.02e-05	0.000174	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	9.69e-06	0.000165	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ADCY5—ulcerative colitis	9.55e-06	0.000162	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CALM3—ulcerative colitis	9.33e-06	0.000158	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPARG—ulcerative colitis	7.12e-06	0.000121	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—JAK2—ulcerative colitis	7.11e-06	0.000121	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ADCY5—ulcerative colitis	6.77e-06	0.000115	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CD4—ulcerative colitis	6.74e-06	0.000114	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALB—ulcerative colitis	6.4e-06	0.000109	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—STAT3—ulcerative colitis	5.22e-06	8.86e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARG—ulcerative colitis	5.05e-06	8.57e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TGFB1—ulcerative colitis	4.84e-06	8.21e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALB—ulcerative colitis	4.54e-06	7.71e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGS2—ulcerative colitis	3.97e-06	6.74e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6—ulcerative colitis	3.64e-06	6.19e-05	CbGpPWpGaD
